This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In May 2024, the Massachusetts Department of Public Health released a troubling report on a cluster of HIV infections, with more than 200 new cases since 2018 attributable to injection drug use in the Boston region.
In 2018, the Food and Drug Administration Safety and Innovation Act (FDASIA) authorized the FDA to apply an accelerated approval mechanism more broadly and created the breakthrough therapy designation, both of which would likely have been considered faster horses by Henry Ford.
Researchers compared survey data from 2018 and 2022, finding that health workers experienced poorer mental health outcomes post-pandemic. Of those surveyed, 46% of health workers reported feeling burnout often or very often in 2022, compared to 32% in 2018. Read the rest…
Then, in 2018, she finally found a drug that kept her ADHD in check. STAT is co-publishing this article by Tradeoffs. Lisa Ann Trainor struggled to stay on top of schoolwork, hold a job or even perform basic tasks like laundry for six exhausting years. Continue to STAT+ to read the full story…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a look at biotech’s latest nadir, the virtues of Neanderthal DNA, and the sudden success of a decades-old idea in oncology. Read the rest…
WASHINGTON — On a bright June day in 2018, one of the nation’s top regulators waved groceries in the air, quizzing the secretary of agriculture on which agency is charged with monitoring different types of food.
These firms — which pool funds from wealthy investors and are exempt from many of the regulations and disclosure requirements that apply to other types of investments — have spent a half-trillion dollars since 2018 buying up medical resources.
Other countries recognized the problem earlier: the United Kingdom appointed a minister for loneliness in 2018; Japan did the same in 2021. It’s been one year since the U.S. surgeon general issued a national warning about an epidemic of loneliness.
” So read the headline of a front-page story in The New York Times in 2018 on a dramatic step Chile was taking to fight obesity. “In Sweeping War on Obesity, Chile slays Tony the Tiger.”
Overdose deaths among pregnant or postpartum people skyrocketed between 2018 and 2021, according to new research published Wednesday in JAMA Psychiatry.
Whichever the case, product recalls by the Food and Drug Administration and the Consumer Product Safety Commission (CPSC) more than doubled between 2018 and 2022, according to new research published on Wednesday by life sciences software company MasterControl. In 2018, the agency only recalled 22 products. In 2022, it recalled 310.
million patients with type 2 diabetes from 2005 to 2018 who were prescribed GLP-1s, insulin, or metformin. New research finds that the GLP-1 class of drugs — glucagon-like peptide receptor agonists — is more effective in mitigating the risk of 10 obesity-associated cancers than its type 2 diabetes drug alternatives.
But since Verve Therapeutics was founded in 2018, it’s had a wider aperture: using the molecular tools of genome editing to go after the most common cause of death in the world. Morgan Healthcare Conference in San Francisco this week.
The first miscarriage happened in June 2018, almost as soon as she found out she was pregnant. — By the time Taylor Teske came to be sitting on an exam table in an obstetrician’s office in Minnesota, her medical records marked a devastating journey: nine pregnancies, one baby, eight miscarriages.
Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.
The biotech is also being led by Spark Therapeutics co-founder Steven Altschuler, who joined Ziff Capital in 2018 as its managing director of health care ventures. Corner Therapeutics’ Series A round was led by Ziff Capital Partners, a little-known family office started by billionaire Dirk Ziff.
They estimated that somewhere between 52,480 and 55,710 people in California died prematurely between 2008-2018 due to chronic exposure to the dangerous particulate matter in wildfire smoke. In a paper published Friday in Science Advances , researchers at UCLA Fielding School of Public Health tried to chip away at that knowledge gap.
billion acquisition of Cerevel Therapeutics , a spinout of Pfizer assets that Bain helped finance back in 2018. The investors have also brought in a familiar face: Ron Renaud, who recently oversaw the $8.7
WASHINGTON — A new trove of internal emails and other documents from the e-cigarette maker Juul reveals the company’s extensive behind-the-scenes efforts to promote its interests in Washington — a rare insight into the otherwise opaque methods corporations use to influence the government.
A Phase 2 study of “dapi” in systemic lupus, conducted in 2018, was negative, although Biogen and UCB saw enough evidence of a treatment effect to keep investing in the drug. Still, the positive outcome is likely to be viewed favorably by investors given the drug’s mixed history.
For now, the Oregon Department of Consumer and Business Services will no longer require drug companies to compile annual reports on price increases, a key feature of a transparency law that was enacted in 2018. The reporting requirements stem from a pair of laws that were enacted in 2018 and 2019. However, a U.S.
Abrams, a frequent commentator about vaping in the news media, including CBS This Morning, CNN, and The New Yorker, coordinated extensively with Juul on public messaging in 2017 and 2018, according to company emails.
Generate was founded in 2018 by venture-creation firm Flagship Pioneering to use machine learning algorithms to identify antibodies, peptides, cell therapies, and other medicines. It launched its first clinical trial in July for a Covid monoclonal antibody, and is working on starting another clinical trial for an asthma treatment.
The company, which absorbed the health insurer Aetna in 2018, marketed its Medicare Advantage plans aggressively last year and expanded its geographic reach more than any insurer. CVS’ operating income fell by 34% — roughly $1.2 Now, that strategy is proving a detriment to its bottom line.
Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. But in biotech, one of the most well-funded AI players has been quiet.
Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary , ProvideGx, with the same aim.
That’s a familiar enough story in biotech: Alnylam won regulatory approval of the first RNAi treatment in 2018, and several other such therapies have followed. City Therapeutics, based in Cambridge, Mass.,
That care, the medical board charged in 2018, was negligent: Anh didn’t collect vital signs, get a reliable medical history, or otherwise verify that his patients were actually sick and needed antibiotics. Another undercover investigator, “Mary Peters,” got antibiotics for a nonexistent urinary tract infection.
Delta 8 THC is a quasi-legal psychoactive version of cannabis, which has skyrocketed in popularity after a loophole found in a 2018 federal law allowed it to be sold nationwide without the same restrictions placed on traditional marijuana.
Universities have also expanded their course offerings, with the number of new students enrolled in accredited midwifery programs growing from 1,006 students in 2014 to 1,214 in 2018 , according to the latest data available. Read the rest…
At Amgen, where he’s led drug research and development since 2018, Reese said this moment has finally arrived. David Reese calls it a “hinge moment” — the turning point when biotech and big tech merge to attack human disease with artificial intelligence.
Even before the Covid pandemic, a 2018 paper reported that new genetic tests, many of them for increasingly rare conditions, were being released at the rate of 10 a day. You can now avail yourself of noninvasive diagnostics that claim to screen for rare birth defects, cancer-associated mutations, and even Alzheimer’s.
He rose to international infamy in 2018, when it came to light that he had performed a series of secretive, ethically fraught , scientifically sloppy genetic experiments that resulted in the birth of three CRISPR’d children.
In 2018, during her chemistry Nobel Prize lecture, Frances Arnold noted that scientists had arrived at a point where they could read, write, and edit any sequence of DNA. But composing whole genes or even whole genomes from scratch — that was something only evolution could do.
Rejoyn has been in development since 2018 and Otsuka is the first drug company to receive FDA clearance for a digital treatment for a mental health condition. ” Patients also receive cognitive behavioral therapy.
Jiankui He, the Chinese scientist who s parked a global uproar in 2018 when he revealed he had created the first gene-edited children , is again out on his own after being dismissed from an academic post.
In a 2018 survey, 45% of respondents managing diabetes reported having intentionally foregone insulin treatment for a period because of the financial burden. Many avoid or ration their treatment because of the high cost. Each new generation of insulin products has been marked by an increase in price.
And the FDA was unable to complete about 30% of one type of common inspection within the requested time frames from fiscal year 2018 through July 2023. By comparison, the FDA inspected 976 clinical study sites in 2017.
In 2018, we came together across party lines to pass the SUPPORT Act, which established vital infrastructure for communities in New Hampshire and across the country to treat addiction, help people recover, and prevent substance misuse in the first place.
In 2018, research found that obesity is the No. Estimates indicate that treating obesity will be expensive, but those sums pale in comparison to the estimated direct and indirect costs of $1.7 trillion that obesity places on the U.S. health care system today. In 2 cause of preventable death in the United States.
A tentative settlement has been reached in a long-running shareholder lawsuit that accused health care activist investor Alex Denner of making nearly $50 million from insider trading in connection with the 2018 acquisition of Bioverativ.
One night in November 2018, I fell while crossing a street in Subic Bay, a U.S. naval logistics station in The Philippines. My face whacked the asphalt. Lying in the path of oncoming traffic, I couldn’t move a muscle. After 45 seconds of terror, I was able to stand up and haul myself to the other side.
278
278
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content